Gene · 1890
Papers4,467
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,467
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Applying causal discovery to single-cell analyses using CausalCell. | Elife | 2023 | 37129360 | PubTator, text mining | PubMed |
| Acute inflammatory reaction during anti-angiogenesis therapy combined with immunotherapy as a possible indicator of the therapeutic effect: Three case reports and literature review. | Front Oncol | 2023 | 37124541 | PubTator, text mining | PubMed |
| The Underexplored Landscape of Hypoxia-Inducible Factor 2 Alpha and Potential Roles in Tumor Macrophages: A Review. | Oxygen (Basel) | 2023 | 37124241 | PubTator, text mining | PubMed |
| Nanoformulations-Based Metronomic Chemotherapy: Mechanism, Challenges, Recent Advances, and Future Perspectives. | Pharmaceutics | 2023 | 37111677 | PubTator, text mining | PubMed |
| Dihydropyrimidone Derivatives as Thymidine Phosphorylase Inhibitors: Inhibition Kinetics, Cytotoxicity, and Molecular Docking. | Molecules | 2023 | 37110867 | PubTator, text mining | PubMed |
| Body weight loss as a prognostic and predictive factor in previously treated patients with metastatic gastric cancer: post hoc analyses of the randomized phase III TAGS trial. | Gastric Cancer | 2023 | 37106214 | PubTator, text mining | PubMed |
| Extending inherited metabolic disorder diagnostics with biomarker interaction visualizations. | Orphanet J Rare Dis | 2023 | 37101200 | PubTator, text mining | PubMed |
| Thymidine phosphorylase facilitates retinoic acid inducible gene-I induced endothelial dysfunction. | Cell Death Dis | 2023 | 37100811 | PubTator, text mining | PubMed |
| Microwave-Assisted Synthesis, Structure, and Preliminary Biological Evaluation of Novel 6-Methoxy-5,6-dihydro-5-azapurines. | ACS Omega | 2023 | 37091407 | PubTator, text mining | PubMed |
| A very early onset MNGIE-like syndrome with POLG1 mutation and accompanying leukoencephalopathy. | Clin Neurol Neurosurg | 2023 | 37084649 | PubTator, text mining | PubMed |
| Targeting neddylation as a novel approach to lung cancer treatment (Review). | Int J Oncol | 2023 | 37083098 | PubTator, text mining | PubMed |
| Oral Capecitabine Exposures and Use of Uridine Triacetate: A 20-Year Retrospective Analysis. | Clin Drug Investig | 2023 | 37072662 | PubTator, text mining | PubMed |
| Cellular resistance mechanisms in cancer and the new approaches to overcome resistance mechanisms chemotherapy. | Saudi Med J | 2023 | 37062547 | PubTator, text mining | PubMed |
| Biomarkers Found in the Tumor Interstitial Fluid may Help Explain the Differential Behavior Among Keratinocyte Carcinomas. | Mol Cell Proteomics | 2023 | 37059366 | PubTator, text mining | PubMed |
| Construction and Validation of Protein Expression-related Prognostic Models in Clear Cell Renal Cell Carcinoma. | J Cancer | 2023 | 37056387 | PubTator, text mining | PubMed |
| Enhancement of immune surveillance in breast cancer by targeting hypoxic tumor endothelium: Can it be an immunological switch point? | Front Oncol | 2023 | 37056346 | PubTator, text mining | PubMed |
| Diagnosing mitochondrial, neurogastrointestinal leukoencephalopathy requires mutations in TYMP1, POLG1, LIG1, or RRM2B. | J Med Case Rep | 2023 | 37055871 | PubTator, text mining | PubMed |
| An Overview of Angiogenesis in Bladder Cancer. | Curr Oncol Rep | 2023 | 37052868 | PubTator, text mining | PubMed |
| Oncolytic Adenoviruses Armed with Co-Stimulatory Molecules for Cancer Treatment. | Cancers (Basel) | 2023 | 37046608 | PubTator, text mining | PubMed |
| Hematopoietic stem cell transplantation with reduced toxicity conditioning regimen in mitochondrial neurogastrointestinal encephalopathy syndrome. | Pediatr Blood Cancer | 2023 | 37046411 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1890/papers?page=16